Tag: pharmaceuticals
-
Computer-Designed Antibodies Target Alzheimer’s Proteins
Researchers in Europe designed antibodies, like those in the immune system, to attack protein deposits in the brain associated with Alzheimer’s disease.
-
Commercial-Scale Flu Vaccine Produced in Cell Cultures
A vaccine developer says it produced large quantities of a current influenza vaccine for distribution to clinics and hospitals, grown in animal cell cultures rather than eggs.
-
Organ Chips to be Studied on Space Station
A range of biological functions will be assessed with model organs on plastic chips in a series of experiments on the International Space Station.
-
FDA Approves Skin Infection Drug
The U.S. Food and Drug Administration approved a new drug that treats serious bacterial skin infections, including those often resistant to current antibiotics.
-
Cancer Drug Produced in Small Continuous-Flow Batches
A team from drug maker Eli Lilly & Company devised techniques for producing an experimental cancer drug in small quantities but with safe, economical methods used in continuous flow manufacturing.
-
Supreme Court Cuts Biosimilar Waiting Time
The U.S. Supreme Court ruled yesterday that makers of biologic drugs similar to branded originals need not wait an additional 6 months to begin marketing their products.
-
Pharma Company Seeking Digital Tech Partners
Drug maker AstraZeneca is seeking partners to develop solutions with digital technology to accelerate clinical trials and improve health outcomes for patients.
-
Acne Drug Shown to Treat Early Multiple Sclerosis
A clinical trial in Canada shows a common and inexpensive antibiotic to treat acne can reduce the chance early-stage multiple sclerosis becomes a full-blown disease.
-
Precision Medicine Trial Shows Reduced Pain, Opioid Use
A large-scale clinical trial tracking pain treatments guided by genetic testing shows large majorities of participants report less pain, with fewer individuals using opioid drugs.
-
Engineered Immune Cells to be Explored for Solid Tumors
A cancer research center and biotechnology company will examine genetically engineered immune system cells as possible treatments for solid tumor cancers.